Atlassian Corporation PLC vs 22nd Century Group Inc — how do they compare? Atlassian Corporation PLC trades at $206.79 (market cap $51.53B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Atlassian Corporation PLC is far larger — about 82889.6× 22nd Century Group Inc's market cap, and Atlassian Corporation PLC is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Atlassian Corporation PLC for 65 Days and 22nd Century Group Inc for 32 Days on average.
| TEAM | XXII | |
|---|---|---|
Market Cap | $51.53B | $621.67K |
Volume | 2,904,511 | 45,625 |
Sector | Technology | Consumer Staples |
52-Week High | $203.57 | $483.00 |
52-Week Low | $57.15 | $0.80 |
Typical Hold Time | 65 Days | 32 Days |
Enterprise Value | $51.52B | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
Atlassian (TEAM) trades at $203.57, up 4.04% with strong technical momentum and bullish moving averages. The company shows accelerating revenue growth from $5.22B in 2025 to projected $6.6B in 2026, though it remains unprofitable with a -0.82% net margin. Recent earnings beats and strong analyst sentiment (69.77% buy ratings) support the positive outlook, while the stock trades above the consensus price target of $191.16.
TEAM offers growth exposure to enterprise software and AI adoption, with cloud revenue up 31% and 95% subscription mix. However, high valuations (P/S 8.06, EV/EBITDA 242.85) and persistent losses create risk if growth slows. The stock faces resistance near $206-212 with RSI suggesting potential overbought conditions near-term.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →